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MICU1 and MICU2 Operate Together to Regulate the Uniporter
Kimberli J. Kamer1, Vamsi K. Mootha2,3.
1Chemistry and Chemical Biology, Harvard University, Cambridge, MA,
USA, 2Molecular Biology, HHMI, Massachusetts General Hospital, Boston,
MA, USA, 3Systems Biology, Harvard Medical School, Boston, MA, USA.
The mitochondrial calcium uniporter is regulated by the calcium binding,
EF hand-containing proteins MICU1 and MICU2. These proteins reside in
the intermembrane space and physically and functionally interact with the
uniporter channel. While MICU1 and MICU2 are paralogous proteins, we
now establish that their roles are complementary and nonredundant. Both
proteins appear to be involved in inhibiting calcium uptake when calcium
levels are low, while allowing calcium transport when levels rise. Mutations
to the EF hand domains suggest that this inhibition is accomplished by the
apo state (calcium free) of MICU1 and MICU2. Finally, the association of
MICU2 with MCU, the pore-forming subunit, appears to require MICU1, but
MICU1 interacts with MCU even in the absence of MICU2. Taken together,
our results suggest that MICU1 and MICU2 play complementary roles in the
regulation of the uniporter.
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Activation of Mitochondrial SK Channels in Cardiomyocytes Derived
from Hypertrophic Hearts Attenuates Ca2D-Dependent Arrhythmia by
Reducing Mitochondrial ROS Production Thereby Stabilizing RyRs
TaeYun Kim, Weiyan Li, Karim Roder, Radmila Terentyeva, Gideon Koren,
Bum-Rak Choi, Dmitry Terentyev.
Medicine, Brown University and Rhode Island Hospital, Providence,
RI, USA.
Small conductance Ca2þ-activated Kþ (SK) channels were recently dis-
covered in mitochondria inner membrane. Activation of these voltage-inde-
pendent channels was found to be protective against ischemia-reperfusion
injury by reducing intracellular levels of reactive oxygen species (ROS).
Considering submicromolar [Ca2þ] sensitivity of SKs we hypothesized that
these channels may play an important role in cardiac hypertrophy. To inves-
tigate the role of mSK channels in cardiac hypertrophy we used a rat model
of pressure-overload induced by ligation of ascending aorta (TAB). Using
confocal Ca2þ imaging and patch-clamp we found that inhibition of SK
channels with cell-permeable inhibitor UCL-1468 (1 uM) increased frequency
of spontaneous Ca2þ waves (SCWs) and delayed afterdepolarizations
(DADs) in TAB ventricular myocytes (TCMs). Conversely, membrane-
permeable SK enhancer CyPPA (10 uM) attenuated pro-arrhythmic SCWs
and DADs in TCMs. Furthermore, inhibition of mSKs enhanced; and activa-
tion reduced ROS production by mitochondria in TCMs measured with Mito-
Sox. Monobromobimane assay demonstrated that increased oxidation of
ryanodine receptors (RyRs) in TCMs was reversed by CyPPA. Experiments
in permeabilized myocytes showed that CyPPA was unable to completely
reverse increase in spark frequency in TCMs. However, incubation of
TCMs with CyPPA restored SR Ca2þ content, suggestive of substantial
improvement in RyR function. Optical mapping experiments of TAB hearts
using dual Ca2þ and membrane potential imaging revealed that incubation
with membrane-permeable SK activator NS309 (2 uM) improved aberrant
Ca2þ homeostasis and abolished DADs and VT/VF induced by beta-
adrenergic stimulation. These data suggest that pharmacological activation
of mSK channels in hypertrophy protects from Ca2þ-dependent arrhythmia
via reduction of mitochondrial ROS, and thereby reduction of oxidized RyR
leading to its stabilization.
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Altered Ryanodine Receptor Function in Ischemic Heart Disease: Is there
a Role for Mitochondria?
Demetrio J. Santiago, Eef Dries, Ilse Lenaerts, Karin R. Sipido.
Experimental Cardiology, KU Leuven, Leuven, Belgium.
Ventricular myocytes remodel after myocardial infarction (MI). Myocytes
hypertrophy, mitochondria are affected and the density of T-tubules reduces,
while their distance to ryanodine receptors (RyRs) and mitochondria increases.
Reactive oxygen species (ROS) production may increase and modulate RyR
function within microdomains. We investigated the hypothesis that distance
to mitochondria may be an independent determinant of RyR activity, in partic-
ular after MI.
We studied permeabilized myocytes, where the influences of sarcolemma,
bulk [Ca] and [ROS] in sham vs. MI are minimized. Cells were isolated
from 6-weeks post-MI pig hearts, from the area adjacent to the MI and match-ing tissue in sham. xyt scanning served to characterize Ca sparks at the focal
plane, relative to the xyz distribution of mitochondria. Mitochondrial z-stacks
were processed using standard procedures, while a xyt spark detector sharing
features with published algorithms [Kong et al (2008) Biophys J.
95(12):6016-24; Ba´nya´sz et al. (2007) Biophys J. 92(12):4458-65] was created.
Spark frequency was plotted as a function of the distance between each spark’s
center of mass (at first detection) and its closest outer mitochondrial membrane
(OMM).
Control experiments in healthy permeabilized cells showed that, in our condi-
tions, ROS were produced by mitochondria. In healthy and diseased myocytes,
most sparks occurred within 0.5 microns of an OMM. However, it was found
that the relationship between spark frequency and spark center-OMM distance
did not change with MI. Yet in experiments in intact cells, scavenging of
mitochondrial ROS affected spark production in MI predominantly in RyRs
at a distance from the T-tubules. These results might indicate that ROS pro-
duction by mitochondria likely affects all RyRs due to their ubiquitous nature
but that further regulatory factors of RyR activity may be related to the pres-
ence of an intact sarcolemma.
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Statin Induced Myopathy: A Role for Mitochondrial Ca2D and No in
Enhanced Sarcoplasmic Reticulum Ca2D Leak
Sabine Lotteau, David MacDougall, Derek Steele, Sarah Calaghan.
Faculty of Biological Sciences, School of Biomedical Sciences, Leeds,
United Kingdom.
The need to understand the mechanism of statin-induced myopathy is
increasing as the cardiovascular risk threshold for statin prescription is
reduced across the globe. Here we determine for the first time the effect of
chronic statin treatment in vivo (simvastatin 40 mg/kg/day by oral gavage
over a 4 week period) on Ca2þ homeostasis in intact (non-permeabilised)
type II rat skeletal muscle fibres, and investigate a role for mitochondria
and NO. In fluo-4 loaded FDB fibres, sarcoplasmic reticulum (SR) Ca2þ
leak (indexed in the presence of the SERCA inhibitor cyclopiazonic acid)
was significantly higher (P<0.05) following statin treatment. This could be
explained by the observed increase (P<0.001) in the frequency and dura-
tion of Ca2þ sparks/embers in statin fibres. Interestingly, inhibition of the
mitochondrial Ca2þ uniporter by Ru360 in statin fibres normalised spark fre-
quency and duration to control levels (P<0.05), suggesting that mitochondrial
Ca2þ uptake contributes to statin effects on SR Ca2þ release. NOS inhibition
with L-NAME had a greater impact (P<0.05) on NO (indexed with DAF-2)
in statin fibres compared with controls, suggesting increased NOS activity
with statin treatment. This is consistent with reduced expression (P<0.05)
of GAPDH-normalised caveolin 1 and 3 in gastrocnemius muscle from
statin treated animals; caveolins are the main constitutive inhibitors of
nNOS and eNOS. Together these data show for the first time that statin
treatment enhances SR Ca2þ leak in intact muscle fibres. We propose that
Ca2þ-dependent mitochondrial ROS production and NO modify RyR to effect
this leak. Defining the cellular processes that underlie statin induced myo-
pathy is the first step in the development of co-therapies to improve statin
compliance.
Sponsored by the British Heart Foundation.
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Rieske Iron-Sulfur Protein-Dependent Mitochondrial ROS-Mediated
Dissociation of FKBP12.6/RyR2 Complex Plays an Essential Role in
Pulmonary Hypertension
Yong-Xiao Wang, Yun-Min Zheng.
Center for Cardiovascular Sciences, Albany Medical College, Albany,
NY, USA.
An abnormal increase in intracellular calcium concentration ([Ca2þ]i, i.e.,
Ca2þ signaling) in pulmonary artery smooth muscle cells (PASMCs) has
been generally believed to play an essential role in the development of pul-
monary artery contraction and remodeling, thereby leading to devastating
pulmonary hypertension. However, it is unclear which and how ion channels
may mediate the abnormal increase in Ca2þ signaling in PASMCs and
associated pulmonary hypertension. Herein we have for the first time found
that RyR activity and Ca2þ release are significantly increased in PASMCs
from mice with hypoxia-induced pulmonary hypertension, a most common
type of pulmonary hypertension in clinic. Consistent with the increased
RyR functions, SMC-specific RyR2 knockout (RyR2-/-) mice neither
show the increased RyR activity and Ca2þ release nor develop pulmonary
hypertension in mice following hypoxic exposure. Subcutaneous infusion
of the RyR blocker tetracaine produces similar inhibitory effects. Our
biochemical studies demonstrate that the endogenous RyR2 stabilizer
(inhibitor) FK506 binding protein 12.6 (FKBP12.6) is dissociated from
568a Wednesday, February 11, 2015RyR2 in PASMCs from mice with pulmonary hypertension. FKBP12.6
knockout promotes, while subcutaneous infusion of the FKBP12.6 stabilizer
S107 prevents, the development of pulmonary hypertension. Intravenous in-
jection of lentiviral shRNAs specific for mitochondrial Rieske iron-sulfur
protein (RISP) gene blocks the increased generation of PASMCs reactive
oxygen species (ROS), dissociation of FKBP12.6/RyR2 complex, and
pulmonary hypertension in mice. Taken together, we conclude that RISP-
dependent mitochondrial ROS production may cause FKBP12.6/RyR2
complex dissociation, RyR2 hyperfunctions and Ca2þ release in PASMCs,
which leads to pulmonary hypertension. Presumably, specific interventions
targeted at RyR2, FKBP12.6 and RISP may become new and effective
therapeutic strategies to treat pulmonary hypertension and other relevant
vascular diseases.
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Calcium Signaling among RyR2s within a Calcium Release Unit during a
Calcium Spark
Didier X.P. Brochet1, Gang Wang2, W. Jonathan Lederer1, Heping Cheng2.
1Physiology, BioMET, Baltimore, MD, USA, 2Peking University, Beijing,
China.
Although Ca2þ sparks were discovered more than two decades ago, very little
is known about the interactions among the different RyR2s within a dyad
(i.e. a Ca2þ release unit, CRU) during a Ca2þ spark. Examination of Ca2þ
signaling within cardiac ventricular myocytes by targeting the nanoscopic
‘‘subspace’’ of cardiac dyads (using a triadin or junctin-targeted Ca2þ sensor)
was carried out in conjunction with simultaneous visualization of Ca2þ dy-
namics within the cytosol (using rhod-2) and within the sarcoplasmic reticu-
lum (using Fluo-5N). This combination of Ca2þ signals enabled us to unravel
the sequence of activation of the different RyR2s within a dyad during a Ca2þ
spark. A Ca2þ spark is first initiated by the activation of a single RyR2 on the
edge of the array of RyR2s that will in turn activate several RyR2s within the
array which activation will propagate by local CICR to the rest of the array.
The order of activation of the RyR2s is stochastic, meaning that every Ca2þ
sparks are different. Furthermore, the fewer RyR2s that were activated within
the cluster at the CRU, the smaller the width of sparks. Increasing the Ca2þ
buffer capacity with EGTA will both narrow the Ca2þ spark width and also
decrease the frequency. In this context, Quarky Ca2þ release events (QCRs)
correspond to the activation of one or a very few RyR2s. Taken together,
these results suggest that the intra-CRU communication between RyR2s
during a Ca2þ spark may be very important for our understanding of diseases
associated with altered Ca2þ signaling such as arrhythmogenesis and heart
failure.
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Bioorthogonal Calcium Modulation by Direct Intracellular Access using
Nanostraws
Alexander Xu, Amin Aalipour, Sally Kim, Nicholas Melosh.
Stanford University, Stanford, CA, USA.
Ionic calcium plays a ubiquitous role in cell signaling. Calcium signaling uses
numerous mechanisms for regulation including coordinated transport across
cell membranes, internal sequestration and storage, and various specific and
nonspecific buffers. These mechanisms make the generation of ectopic calcium
signals difficult, especially if minimal cell perturbation is required. Neverthe-
less, manipulating calcium effectively is necessary to study how the cell signals
using calcium. Patch clamp pipettes can control intracellular ionic content in
single cells for a limited time. To increase the number of cells studied, chemical
methods for controlling intracellular calcium can be used such as phorbol
ester stimulation or thapsigargin release of calcium storage. These indirect
methods can conflate different signaling pathways with calcium signaling.
To isolate intracellular calcium from other cell functions, techniques which
do not rely on biological mechanisms of release are needed, such as calcium
photouncaging, which uses external light. Here, we propose an alternate strat-
egy to introduce calcium to cells in a bioorthogonal fashion to minimize the
biological footprint. Based on a gap junction-like architecture, we fabricated
a system of supported nanotubes, called nanostraws. Due to their high aspect
ratio (10:1), the nanostraws penetrate into the cell to allow fluidic exchange
between the cell and an external reservoir, which we use to deliver calcium.
We focus on generating temporal signal patterns and controlling the quantity
of calcium delivered to the cell. To demonstrate the bioorthogonality of nano-
straw calcium modulation, we also show that calcium signals can be elicited
through normal stimulation methods. This technique represents a microfluidic
technique to manipulate intracellular calcium which requires no chemical
modification of cells, and the fluidic nature of the delivery can be leveraged
to expand the delivery cargo to other biological ions such as zinc or more
complex biomolecules.2877-Pos Board B307
Effects of Arrhythmogenic Mutations on Ca2D-Induced Ca2D Release
Activities of Type 2 Ryanodine Receptors
Nagomi Kurebayashi1, Takashi Murayama1, Junji Suzuki2,
Kazunori Kanemaru2, Masamitsu Iino2, Takashi Sakurai1.
1Dept. of Pharmacology, Juntendo University School of Medicine, Tokyo,
Japan, 2Dept. of Pharmacology, The University of Tokyo, Tokyo, Japan.
Type 2 ryanodine receptor (RyR2) is a Ca2þ release channel on the sarco-
plasmic reticulum and plays a pivotal role in excitation-contraction coupling
in heart. RyR2 is the major target for arrhythmogenic diseases, e.g., catechol-
aminergic polymorphic ventricular tachycardia (CPVT) and arrhythmogenic
right ventricular cardiomyopathy (ARVC). To date, over 150 mutations have
been identified in the RyR2 gene of CPVT and ARVC patients. It is widely
believed that CPVT and ARVC mutations cause hyperactivation of Ca2þ
release and result in ventricular arrhythmia by abnormal Ca2þ homeostasis in
cardiac muscle. The RyR2 channel is known to be regulated by both cyto-
plasmic Ca2þ (Ca2þ induced Ca2þ release: CICR) and luminal Ca2þ (store
overload induced Ca2þ release: SOICR). It is well documented that the SOICR
threshold and termination levels are affected in the disease-associated muta-
tions, whereas it remains unclear how these mutations affect CICR. CICR
shows biphasic Ca2þ dependence against cytoplasmic Ca2þ, thus the activity
can be determined by three parameters: sensitivity to activating Ca2þ, sensi-
tivity to inactivating Ca2þ, and the gain (i.e., peak activity). In this study, we
expressed RyR2 channels carrying CPVT and ARVC mutations in HEK cells
and tested their Ca2þ homeostasis by live-cell Ca2þ imaging using gene-
encoded Ca2þ indicators for optical imaging (GECO) and calcium-measuring
organelle-entrapped protein indicators (CEPIA). In addition, three parameters
of CICR activity was determined with [3H]ryanodine binding assay. Our results
suggest that the disease-associated mutations divergently affects the parameters
of CICR depending on the sites for mutation. The underlying molecular mech-
anism will be discussed.
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DHBP Block of Ryanodine Receptor Channels
Yuanzhao Lv, Julio A. Copello.
Pharmacology, Southern Illinois University, Springfield, IL, USA.
1,10-diheptyl-4,40-bipyridinium dibromide (DHBP), a divalent organic cation,
was reported to inhibit muscle contraction, which was attributed to inhibition
of ryanodine receptor (RyR) mediated Ca2þ release from the sarcoplasmic
reticulum (SR). Still, single RyR channel studies are lacking and the mecha-
nism by which DHBP blocks RyRs is unknown. We reconstituted RyRs from
skeletal muscle and heart SR microsomes into planar bilayers. We observed
with DHBP addition to the cytosolic surface of RyRs (clamped at Vm ¼
0 mV) decreased channel conductance (IC50 ~ 1 mM). The percentage block
in channel conductance elicited by DHBP was invariable in the range 30
to þ30 mV. DHBP did not affect RyR gating characteristics, which was
measured under Ca2þ conditions that produced low, moderate or high Po
and in the presence/absence of physiological modulators (ATP, Mg2þ).
DHBP added to luminal and cytosolic sides of the RyRs, resulted in additive
effects on channel conductance. DHBP also induced inhibition of RyR-
mediated SR Ca2þ release from skeletal SR microsomes. A similar block of
RyRs conductance was observed with other bipyridinum derivatives, none
of which affected SERCA ATPase activity. Previous reports in the literature
indicated block of RyRs by DHBP in cells required lower drug concentrations,
suggesting a possible cellular mechanism of DHBP accumulation. In sum-
mary, DHBP blocks RyRs Ca2þ conductance resembling the action of poly-
amines and organic cations. DHBP properties make it an attractive
experimental probe for understanding the role of RyR conductance in Ca2þ
release from intracellular Ca2þ stores (Supported by American Heart Associ-
ation and Eskridge Foundation).
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Filling the Gap Between Calcium Sparks andWaves: Automatic Detection
and Classification of Local Calcium Releases in Cardiac Pacemaker Cells
Alexander V. Maltsev, Michael D. Stern.
Laboratory of Cardiovascular Science, National Institute on Aging, NIH,
Baltimore, MD, USA.
Local calcium releases (LCRs) observed in cardiac pacemaker cells have a
complex spatiotemporal structure that has never been studied. We developed
a computer algorithm for automatic detection and classification of LCRs in
simulations of rabbit sinoatrial-node cells (using our recent 3D-model) to get
new insights into pacemaker cell operation, specifically, the role of sarco-
plasmic reticulum calcium pumping rate (Pup).
Identified release events that share a common intensity level are categorized
as a release cluster, i.e. a complex release with multiple intensity peaks.
